BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-18

  1. 6,564 Posts.
    lightbulb Created with Sketch. 470
    Looks like final correspondence with fda , so pretty much bot and fda engaged with dialogue last week or two for finalisation , unlike last time
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.